SC
PLXP

Shay Capital’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Shay Capital’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-88,620
Closed -$358K – 667
2022
Q1 		$358K Buy
+88,620
New +$486K 0.05% 290

Other funds holding PLXP

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Shay Capital's PLXP Position: Q2 2022 in Review

Shay Capital sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2022, closing a stake of 88,620 shares — an estimated $358K sold.

Shay Capital first reported a position in PLXP in Q1 2022 and held it in 1 quarter. The position peaked at $358K in Q1 2022. 48 funds tracked by Wall St. Rank hold PLXP as of Q2 2022.

  • Shay Capital reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Shay Capital sold 88,620 PLx Pharma Inc. Common Stock shares in Q2 2022, an estimated $358K.
  • Shay Capital first reported a position in PLx Pharma Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Shay Capital's PLx Pharma Inc. Common Stock position peaked at $358K in Q1 2022.
  • 48 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2022.

Based on Shay Capital's 13F filing for Q2 2022, filed 15 Aug 2022.